Ra Capital Management, L.P. Sc Pharmaceuticals Inc. Transaction History

Ra Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $7.46 Million - $14 Million	1,856,904 New	1,856,904 $13.3 Million
Q2 2022 Aug 15, 2022	SELL	$4.3 - $6.48 $11.4 Million - $17.2 Million	-2,658,583 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.9 - $6.11 $129,429 - $202,772	-33,187 Reduced 1.23%	2,658,583 $15.1 Million
Q4 2021 Feb 14, 2022	SELL	$3.88 - $6.9 $152,872 - $271,860	-39,400 Reduced 1.44%	2,691,770 $13.5 Million
Q1 2021 May 17, 2021	SELL	$5.65 - $7.66 $4.45 Million - $6.03 Million	-787,828 Reduced 22.39%	2,731,170 $18.2 Million
Q1 2020 May 15, 2020	BUY	$5.4 - $10.45 $1.47 Million - $2.84 Million	271,993 Added 8.38%	3,518,998 $26 Million
Q2 2019 Aug 14, 2019	BUY	$2.48 - $3.76 $966,857 - $1.47 Million	389,862 Added 13.65%	3,247,005 $10.4 Million
Q4 2017 Feb 14, 2018	BUY	$11.8 - $17.31 $33.7 Million - $49.5 Million	2,857,143	2,857,143 $34.5 Million

100

38.3M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $89.1M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.